Relationship between Elevated Maternal Serum Podocalyxin Concentrations with Blood Pressure Values and Routine Laboratory Parameters in Preeclampsia
Podocalyxin (PCX) is a glycoprotein member of the CD34 transmembrane sialomucin family and covers the surface of podocytes. It is assumed to be a marker of glomerular endothelial injury. In conditions, podocalyxin excretion in the urine is increased as a result of podocyte injury. Recent studies sho...
Saved in:
| Main Authors: | Nikola Popovski, Asparuh Nikolov, Yordan Popov, Svetla Blazheva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2021-12-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34603/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Podocalyxin and kidney diseases
by: I. Kostovska
Published: (2025-04-01) -
Renal Implications of Psoriasis: Urinary Podocyte Markers and Disease Progression
by: Sule Gencoglu, et al.
Published: (2025-04-01) -
A mitochondrial regulator protein, mitofusin 2, is elevated in the maternal blood of women with preeclampsia
by: Dandan Sun, et al.
Published: (2025-05-01) -
Elevated Liver Function Tests as Predictors of Severe Maternal Outcomes in Women with Preeclampsia
by: Sadia Chaudhary, et al.
Published: (2025-01-01) -
Pregestational maternal risk factors for preterm and term preeclampsia: A population‐based cohort study
by: Anne Kvie Sande, et al.
Published: (2023-11-01)